![]() |
Liver Cirrhosis |
Free Subscription
2 Dig Dis Sci |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Liver Cirrhosis is free of charge.
Embracing Imperfect Tools to Decode AKI in Decompensated Cirrhosis.
Dig Dis Sci. 2025 Sep 7. doi: 10.1007/s10620-025-09379.
PubMed
Socioeconomic Factors Impact the Perception of Healthcare Experiences in Patients
with Cirrhosis.
Dig Dis Sci. 2025 Sep 6. doi: 10.1007/s10620-025-09374.
PubMed
Abstract available
Non-invasive tests of fibrosis in the management of MASLD: revolutionising
diagnosis, progression and regression monitoring.
Gut. 2025;74:1741-1750.
PubMed
Abstract available
Erratum to 'Carvedilol vs. propranolol for the prevention of decompensation and
mortality in patients with compensated and decompensated cirrhosis' [J Hepatol 83
(2025) 70-80].
J Hepatol. 2025 Sep 5:S0168-8278(25)02439-0. doi: 10.1016/j.jhep.2025.
PubMed
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH. Reply.
N Engl J Med. 2025;393:10.
PubMed
Efruxifermin in Compensated Liver Cirrhosis Caused by MASH.
N Engl J Med. 2025;393:10.
PubMed
Albumin-corrected anion gap as a predictive marker for mortality in critically
Ill cirrhosis patients: an analysis based on the MIMIC-IV database.
PLoS One. 2025;20:e0332490.
PubMed
Abstract available
Machine learning-based prediction model for 28-day mortality in acute kidney
injury patients with liver cirrhosis: A MIMIC-IV database analysis.
PLoS One. 2025;20:e0328662.
PubMed
Abstract available
Thank you for your interest in scientific medicine.